30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Jaguar to explore approval pathway for crofelemer in breast and lung cancer based on phase 3 resultsClick here to register...
